CORDIS · 101171563 · HORIZON
CLARISURGE Advancing Mountable Endoscopic Cap for Precision Oesophageal Mucosal Resurfacing with Non-Thermal Ablation
Coordinator: IZMIR BIYOTIP VE GENOM MERKEZI (TR)
Treatments that minimize adverse effects on deep tissues may be critical for successful therapy in a superficial pre-cancerous condition such as Barrett's oesophagus. Although endoscopic therapeutic interventions efficiently eradicate superficial abnormal tissues in the oesophagus, the main challenge with their current deployments is that the therapy depth typically has a more profound thermal injury than the target layer. The project's objective is to develop a novel endoscopic cap that provides local non-thermal ablation to the superficial layers of the target oesophageal wall with sufficie…
About Horizon Europe (2021–2027)
Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.
EU contribution: €1.6M awarded to the consortium. The project runs over approximately 5 years from 2025-05-01 to 2030-04-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from TR
see all →- CoCirculation3 — CO-FUNDED Brain Circulation 3101179377 · HORIZON · €9.6M
- TEAM-NANO — Teaming for Capacity Development and Synergies in Micro-nanofabrication and Flexible Electronics for Widespread Impact101136388 · HORIZON · €9.0M
- SHEREC — SAFE, HEALTHY AND ENVIRONMENTAL SHIP RECYCLING101136056 · HORIZON · €8.0M
- CoCirculation2 — CO-FUNDED Brain Circulation Scheme 2801509 · H2020 · €6.2M
- DIAMETER — Demonstration of a sustainable circular-by-design manufacturing system based on additive manufacturing101177422 · HORIZON · €6.0M
- HSMonitor — Pre-commercial Procurement of innovative ICT-enabled monitoring to improve health status and optimise hypertension care856698 · H2020 · €5.9M
Other HORIZON projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon Europe through a joint programme of the members of the EUROfusion consortium101052200 · DE · €549.4M
- EITUM-BP26-28 — EIT Urban Mobility Business Plan 2026-2028101269525 · ES · €206.9M
- PARC — Partnership for the Assessment of Risks from Chemicals101057014 · FR · €200.0M
- EIT RM BP23-25 — EIT RawMatrials Business Plan 2023-2025101113034 · DE · €155.5M
- SGA1-HE — COST: Europe's most empowering research programme Strengthening science and innovation through research networking101052416 · BE · €153.0M
- EIT HEI — EIT Higher Education Initiative - Scaling Europe’s Innovation Ecosystems101270329 · DE · €130.0M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-ERC funding scheme.
- What is the EU contribution?
- The European Commission contributes €1.6M toward a total project budget of €1.6M.
- Which EU programme funds it?
- The project is funded under Horizon Europe (2021–2027), call ERC-2024-COG.
- Who coordinates the project?
- The project is coordinated by IZMIR BIYOTIP VE GENOM MERKEZI (TR).
- What is the project timeline?
- The project runs from 2025-05-01 to 2030-04-30 — approximately 5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101171563.